PTC Therapeutics PTCT Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from PTC Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: PTC Therapeutics’s 10-Q, filed May 6, 2025, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's free cash flow margin?
- PTC Therapeutics (PTCT) reported free cash flow margin of 39.1% in Q1 2025.
- How has PTC Therapeutics's free cash flow margin changed year-over-year?
- PTC Therapeutics's free cash flow margin increased by 522.0% year-over-year, from -9.3% to 39.1%.
- What is the long-term trend for PTC Therapeutics's free cash flow margin?
- Over 3 years (2021 to 2024), PTC Therapeutics's free cash flow margin has grown at a -35.2% compound annual growth rate (CAGR), from -51.9% to -14.2%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.